371 related articles for article (PubMed ID: 31779058)
1. Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
Ahn KC; Learman CR; Baker GB; Weaver CL; Chung PS; Kim HG; Song MS
J Korean Med Sci; 2019 Dec; 34(46):e297. PubMed ID: 31779058
[TBL] [Abstract][Full Text] [Related]
2. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
[TBL] [Abstract][Full Text] [Related]
3. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
Ahmed AS; Elgharabawy RM; Al-Najjar AH
Exp Biol Med (Maywood); 2017 Jul; 242(13):1335-1344. PubMed ID: 28534431
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
Kimura N
Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
[TBL] [Abstract][Full Text] [Related]
6. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
7. Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues.
Candasamy M; Mohamed Elhassan SA; Kumar Bhattamisra S; Hua WY; Sern LM; Binti Busthamin NA; Mohamad Ilni NB; Shun NS; Baohong L; Ya NS; Ying NW
Panminerva Med; 2020 Sep; 62(3):155-163. PubMed ID: 32208408
[TBL] [Abstract][Full Text] [Related]
8. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
[TBL] [Abstract][Full Text] [Related]
9. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
12. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
[TBL] [Abstract][Full Text] [Related]
13. Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease.
Jojo GM; Kuppusamy G
J Clin Pharm Ther; 2019 Jun; 44(3):337-348. PubMed ID: 30738020
[TBL] [Abstract][Full Text] [Related]
14. Diabetes drugs in the fight against Alzheimer's disease.
Boccardi V; Murasecco I; Mecocci P
Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte and Alzheimer's disease.
Cai Z; Wan CQ; Liu Z
J Neurol; 2017 Oct; 264(10):2068-2074. PubMed ID: 28821953
[TBL] [Abstract][Full Text] [Related]
16. Common features between diabetes mellitus and Alzheimer's disease.
Götz J; Ittner LM; Lim YA
Cell Mol Life Sci; 2009 Apr; 66(8):1321-5. PubMed ID: 19266159
[TBL] [Abstract][Full Text] [Related]
17. Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings.
Khezri MR; Yousefi K; Mahboubi N; Hodaei D; Ghasemnejad-Berenji M
Biochem Pharmacol; 2022 Mar; 197():114945. PubMed ID: 35134385
[TBL] [Abstract][Full Text] [Related]
18. Type 2 Diabetes Mellitus and Alzheimer's Disease: A Review of the Potential Links.
Pakdin M; Toutounchian S; Namazi S; Arabpour Z; Pouladi A; Afsahi S; Poudineh M; Nasab MMM; Yaghoobpoor S; Deravi N
Curr Diabetes Rev; 2022; 18(8):e051121197760. PubMed ID: 34749616
[TBL] [Abstract][Full Text] [Related]
19. Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1β Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
Verma N; Ly H; Liu M; Chen J; Zhu H; Chow M; Hersh LB; Despa F
J Alzheimers Dis; 2016 May; 53(1):259-72. PubMed ID: 27163815
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
